Health care Why the approval of Eli Lilly’s tirzepatide for diabetes will lead to blockbuster sales May 14, 2022By On Friday, Eli Lilly (LLY) won approval of Mounjaro (tirzepatide), a novel once-weekly injectable medicine for type 2 diabetes. Related Posts Health care Three Ways to Boost Your HGH (Human Growth Hormone) Levels May 27, 2022February 4, 2022By shiva Health care Skin “Feed” Antioxidants to Your Skin for a Radiant Complexion May 27, 2022February 4, 2022By shiva
